Trial intelligence / Profile preview

Itraconazole and CCRT in Locally Advanced ESCC

NCT04481100Phase 2Unknown

Start
Oct 2020
Primary completion
Jul 2021
Countries
1
01

Overview

A Phase 2 trial of itraconazole in Esophageal Squamous Cell Carcinoma (ESCC). Status: unknown.

02

Drugs

itraconazole
03

Conditions

Esophageal Squamous Cell Carcinoma (ESCC)

Beyond the preview

Go deeper on NCT04481100.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04481100.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call